Workflow
Amwell(AMWL)
icon
Search documents
American Well (AMWL) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
ZACKS· 2025-05-02 00:05
Core Insights - American Well Corporation (AMWL) reported revenue of $66.83 million for the quarter ended March 2025, reflecting a year-over-year increase of 12.3% and exceeding the Zacks Consensus Estimate by 11.18% [1] - The company's EPS was -$1.73, an improvement from -$5.00 in the same quarter last year, with a surprise of 44.01% compared to the consensus estimate of -$3.09 [1] Revenue Breakdown - Platform subscription revenue was $32.21 million, slightly below the average estimate of $32.89 million, but showed a year-over-year increase of 29.6% [4] - Other revenue reached $8 million, significantly surpassing the average estimate of $3.61 million, marking a year-over-year increase of 122.8% [4] - Revenue from visits was $26.63 million, which was above the average estimate of $23.70 million, but represented a year-over-year decline of 14.3% [4] Stock Performance - Over the past month, shares of American Well have returned +2.5%, contrasting with a -0.7% change in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the broader market in the near term [3]
American Well Corporation (AMWL) Reports Q1 Loss, Tops Revenue Estimates
ZACKS· 2025-05-01 23:25
American Well Corporation (AMWL) came out with a quarterly loss of $1.73 per share versus the Zacks Consensus Estimate of a loss of $3.09. This compares to loss of $5 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 44.01%. A quarter ago, it was expected that this company would post a loss of $2.82 per share when it actually produced a loss of $2.77, delivering a surprise of 1.77%.Over the last four quarters, the company has su ...
Amwell(AMWL) - 2025 Q1 - Earnings Call Transcript
2025-05-01 21:00
American Well (AMWL) Q1 2025 Earnings Call May 01, 2025 05:00 PM ET Speaker0 Good day, and thank you for standing by. Welcome to the AmWell First Quarter twenty twenty five Earnings Conference Call. At this time, all participants are in a listen only mode. After the speakers' presentation, there will be a question and answer session. Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Sue Dewey, Head of Investor Relations for Amwel ...
Amwell(AMWL) - 2025 Q1 - Quarterly Report
2025-05-01 20:13
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39515 American Well Corporation (Exact name of registrant as specified in its charter) (State of incorporation) (I.R.S. Employer D ...
Amwell(AMWL) - 2025 Q1 - Quarterly Results
2025-05-01 20:10
Amwell ® Announces Results for the First Quarter Ended March 31, 2025 Exhibit 99.1 BOSTON – May 1, 2025 – Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced financial results for the first quarter of 2025. "We had a strong Q1 across all our strategic initiatives. Together with our Leidos partners, we advanced our progress in the staged launch of our full solution across the Military Health System. We also made significant progress ...
Amwell® Announces Results for First Quarter 2025
GlobeNewswire· 2025-05-01 20:05
BOSTON, May 01, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL) a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced financial results for the first quarter ended March 31. Visit Amwell’s investor relations website at investors.amwell.com to view the first quarter 2025 earnings report. The company will host a conference call to discuss its financial results today at 5 p.m. ET, May 1. The call can be accessed via a live audio webcast at https://edge.media-ser ...
Amwell® to participate in upcoming investor conferences
Newsfilter· 2025-04-24 11:30
BOSTON, April 24, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE:AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, will participate in the following upcoming investor conferences:   On May 8, Mark Hirschhorn, chief financial officer and chief operating officer, will participate in one-on-one meetings at the Needham & Co. Virtual Technology and Services Conference held virtually. On June 24, Hirschhorn will participate in the Truist Securities Healthcare Dis ...
Amwell® to report first quarter 2025 operating results
GlobeNewswire· 2025-04-17 11:05
BOSTON, April 17, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leader in digital care, will report first quarter 2025 operating results after stock market trading hours on Thursday, May 1 2025. Following the distribution of the earnings alert via wire services, the Amwell management team will host a live conference call and webcast at 5 p.m. ET to review the company's operating results and provide a general business update. The full earnings report and the live audio webcast can be accessed by visiting ...
Amwell makes inducement grant
GlobeNewswire· 2025-03-03 21:05
BOSTON, March 03, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leader in technology-enabled care, today announced that, on March 3, 2025, it made a grant of restricted stock units (“RSUs”) covering 220,844 shares of its Class A common stock to Dan Zamansky. The grant was offered as material inducement to Zamansky’s employment as Amwell’s chief product and technology officer. The RSUs become vested as follows, subject to Zamansky’s continued employment through each vesting date, except as noted below: 25 ...
Amwell announces innovation leader as chief product and technology officer
GlobeNewswire· 2025-03-03 13:05
Amazon veteran Dan Zamansky joins company’s executive teamBOSTON, March 03, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leader in technology-enabled care, announced Dan Zamansky, an industry leader in innovation and technology, as the company’s new chief product and technology officer, effective today. Zamansky will lead the company's product and R&D organizations. He will focus on the comprehensive technology-enabled care platform Amwell offers payers and health systems to provide individuals with bet ...